Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 16, 2026
Figma (FIG): Why the $30 Target (+18% Upside) Remains a Key Focus

Figma (FIG): Why the $30 Target (+18% Upside) Remains a Key Focus

Key Takeaways

  • Target in focus: The $30 level is the most widely discussed near-term stock price target for Figma, Inc. (NYSE: FIG), about 18% above the most recent close of $25.42.
  • Strongest bullish factors: Accelerating revenue growth, high customer retention, and early evidence that AI features are driving paid adoption rather than displacing the platform.
  • Biggest obstacles: AI-native competition, rising AI compute costs, continued GAAP losses, insider selling, and a premium valuation.
  • Key levels: Nearby support sits around $24–$25, with the 52-week low near $16.60; resistance appears near $26.50, followed by the psychological $30 zone.
  • Bottom line: Reaching $30 is plausible but not guaranteed; it likely requires sustained 30%-plus revenue growth and clearer AI-driven margin expansion.

Why the $30 Level Matters to Investors

The $30 price objective has become the focal point of the FIG debate because it is both a psychological round number and the level where much of Wall Street research has converged. Several major banks carry $30 targets on the stock, and with shares closing at $25.42 on Aug. 14, 2026, that target implies meaningful but achievable upside of about 18%. It is close enough to remain relevant, yet far enough to require a genuine catalyst.

Figma at a Glance

Figma, Inc. (NYSE: FIG) is a browser-based collaborative design and product development platform. Its products include Figma Design, FigJam, Dev Mode, and Figma Make, an AI-powered tool for turning prompts into prototypes and applications. Founded in 2012 and headquartered in San Francisco, Figma went public in July 2025. It competes with design-software incumbents such as Adobe and Autodesk, while also facing newer AI-native design tools.

Recent Market Position

FIG has experienced a dramatic reset. After topping out above $140 shortly after its 2025 IPO, the stock has spent much of the past year under pressure and now trades inside a 52-week range of roughly $16.60 to $82.94. The decline came even as operating results improved: in the quarter reported on Aug. 5, 2026, Figma grew revenue 48% year over year to $370 million, posted a non-GAAP gross margin around 85%, and raised full-year guidance again. Shares still fell afterward as investors focused on rising AI inference costs, margin pressure, and an Aug. 8 lockup expiration that added to available share supply.

What Could Drive the Next Leg Higher

The bull case centers on AI becoming a revenue tailwind rather than a threat. Figma has introduced a hybrid AI credit model, and in the first quarter of 2026 more than 75% of enterprise customers who exceeded their included AI credits kept consuming them, according to company data cited by analysts. Customers purchasing AI add-ons have shown roughly three times the average annualized spend of those that do not, while Figma Make adoption has climbed among large accounts. Core subscription metrics remain strong. First-quarter net dollar retention reached 139%, paid customers grew 54% year over year to about 690,000, and customers generating more than $100,000 in annual recurring revenue rose 48%. Sustained growth of that quality would support a re-rating toward the $30 zone. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

What Could Prevent the Move

The bear case is equally clear. Investors remain worried that generative AI tools from large technology platforms and startups could commoditize design work, and competitive product launches have triggered sharp selloffs in the past. Figma is also spending heavily on AI infrastructure, which pressures margins even as revenue accelerates, and the company is not yet consistently profitable under Generally Accepted Accounting Principles (GAAP). Valuation and supply add further friction. The stock trades around 10 times trailing sales, a premium for an unprofitable company, and short interest has been elevated at roughly one-third of the float. Insider sales under pre-arranged 10b5-1 trading plans have also weighed on sentiment.

Analyst Opinions and Price Targets

Wall Street's consensus rating on FIG remains a Buy or Moderate Buy, with an average 12-month price target near $30.50, according to compiled analyst estimates. Targets are clustered around $30: Bank of America and Goldman Sachs have published $30 objectives, while Morgan Stanley and Wells Fargo sit in the low-to-mid $30s, and Citi raised its target to $37 in August 2026. More cautious firms remain in the low $20s to $25 range. The concentration of targets at $30 explains why investors frame the question around that specific level.

Technical Levels That Matter

From a technical analysis perspective, FIG has been stabilizing after a steep decline. The $24–$25 area has acted as near-term support, while $26.50 marks recent resistance. A decisive close above $26.50 would open a path toward the $30 psychological level; a breakdown below $24 would put the $22 zone and ultimately the 52-week low near $16.60 back into focus. The $30 level is therefore both a consensus analyst target and a technical supply zone. When reviewing the setup, I checked Tickeron’s AI Trend Prediction Engine for additional context on momentum.

Final Assessment

Can FIG realistically reach $30? The evidence points to a credible but conditional path. The strongest arguments are accelerating revenue growth, exceptional customer retention, and early proof that AI features are generating incremental spend rather than destroying the core business. The main risks are AI-driven competition, margin compression from heavy AI investment, and a valuation that leaves little room for execution error. If Figma keeps growing revenue by 30% or more and demonstrates that AI spending is converting into profitable, recurring revenue, the $30 level is a realistic objective. If margins deteriorate or competitive pressure intensifies, the stock may remain range-bound below that target. Investors should monitor quarterly revenue growth, AI credit adoption, gross margin, and how shares respond around the $24–$25 support and $26.50 resistance zones.

Enhancing Analysis with AI Monitoring Tools

In my own review of FIG, I’ve found Tickeron’s AI Daily Buy/Sell Signals useful for tracking momentum shifts alongside traditional research. The tool applies artificial intelligence to scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on technical behavior and market conditions. It can help identify opportunities and monitor positions more efficiently as part of a broader process.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FIG

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


FIG's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Oscillator for FIG moved out of overbought territory on August 06, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 instances where the indicator moved out of the overbought zone. In of the 12 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 45 cases where FIG's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for FIG turned negative on August 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FIG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FIG broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 13, 2026. You may want to consider a long position or call options on FIG as a result. In of 67 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

FIG moved above its 50-day moving average on July 27, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where FIG advanced for three days, in of 224 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 107 cases where FIG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. FIG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FIG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.166) is normal, around the industry mean (28.731). P/E Ratio (0.000) is within average values for comparable stocks, (80.819). FIG's Projected Growth (PEG Ratio) (7.952) is very high in comparison to the industry average of (1.729). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (10.526) is also within normal values, averaging (77.792).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), Salesforce (NYSE:CRM), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Datadog (NASDAQ:DDOG), Autodesk (NASDAQ:ADSK), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 10.32B. The market cap for tickers in the group ranges from 291 to 239.81B. SAP holds the highest valuation in this group at 239.81B. The lowest valued company is BLGI at 291.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was -0%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 9%. NIQ experienced the highest price growth at 49%, while NXTT experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was -19%. For the same stocks of the Industry, the average monthly volume growth was 18% and the average quarterly volume growth was -46%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 76
Price Growth Rating: 56
SMR Rating: 78
Profit Risk Rating: 94
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
FIG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Profile
Details
Interact to see
Advertisement
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Cincinnati Financial (CINF) reports Q4 2025 earnings on February 9, 2026, after market close, with consensus EPS of $2.86–$2.89 and revenue around $2.91 billion. Allstate (ALL) recently reported Q4 2025 EPS of $14.31, well above the $8.72 estimate, with revenue of $17.3 billion on February 4, 2026.
(AZN) AstraZeneca’s full-year 2025 results, set for February 10, 2026, cap a year of sustained growth amid competitive pressures. Following 21% total revenue growth in FY 2024 and 19% core EPS expansion, AZN has maintained momentum with 11% revenue growth through nine months of 2025. The report offers insight into:
Gilead Sciences (GILD): Q4 2025 earnings due February 10, consensus EPS $1.83, revenue $7.68B. Growth driven by HIV franchise; oncology investments like Trodelvy may offer upside. Amgen (AMGN): Reported Q4 2025 EPS $5.29 vs $4.73 expected, revenue $9.9B (+9% YoY). Strong 2026 guidance: $37–38.4B revenue, $21.60–23.00 non-GAAP EPS.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
CME Group delivered record 2025 revenue of $6.52 billion, up 6% year-over-year. Q4 adjusted EPS of $2.77 exceeded expectations.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.